Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study GroupElisabetta Degasperi, S. Fagiuoli, S. Zaltron et al.|Digestive and Liver Disease|2018Cited by 0
Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto networkFederica Invernizzi, S. Fagiuoli, L. Pasulo et al.|Digestive and Liver Disease|2018Cited by 0